4 withdrawn. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Withdrawn 4 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Polymyositis: new trials by email Literature Review of Polymyositis trials Research Report on Polymyositis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis Deucravacitinb - Myositis, Dermatomyositis | Phase 2 | Withdrawn | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2025-11-21 | 2025-11-24 | |
| Baricitinib for Cutaneous Dermatomyositis Baricitinib - Dermatomyositis | Phase 2 | Withdrawn | University of Washington | 2022-06-01 | 2023-09-01 | |
| Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders denosumab - Osteoporosis, Juvenile Rheumatoid Arthritis | Phase 1 / Phase 2 | Withdrawn | Indiana University | 2019-08-01 | 2019-12-06 | |
| Study of IFN-K in Dermatomyositis IFN-Kinoid, Placebo, ISA 51 - Dermatomyositis | Phase 2 | Withdrawn | Neovacs | 2017-05-03 | 2020-01-03 |
Dermatomyositis (4) · Arthritis (1) · Arthritis, Juvenile (1) · Myositis (1) · Osteoporosis (1) · Vasculitis (1)
Connective Tissue Diseases (4) · Muscular Diseases (4) · Musculoskeletal Diseases (4) · Nervous System Diseases (4) · Neuromuscular Diseases (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Myositis (3) · Autoimmune Diseases (1) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Cardiovascular Diseases (1) · Immune System Diseases (1) · Joint Diseases (1)
Denosumab (1) · baricitinib (1) · montanide ISA 51 (1)
Indiana University (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1) · Neovacs (1) · University of Washington (1)
United States (3) · France (1) · Germany (1) · Italy (1) · Switzerland (1)
Andrew L Mammen, M.D. (1) · Erik Imel, MD (1) · Kwanghoon Han, MD (1)
2016 (1)